EA201591996A1 - Способы и композиции для заживления раны - Google Patents

Способы и композиции для заживления раны

Info

Publication number
EA201591996A1
EA201591996A1 EA201591996A EA201591996A EA201591996A1 EA 201591996 A1 EA201591996 A1 EA 201591996A1 EA 201591996 A EA201591996 A EA 201591996A EA 201591996 A EA201591996 A EA 201591996A EA 201591996 A1 EA201591996 A1 EA 201591996A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
wound healing
epoxy
healing
compositions
Prior art date
Application number
EA201591996A
Other languages
English (en)
Other versions
EA032501B9 (ru
EA032501B1 (ru
Inventor
Пол Уоррен Редделл
Виктория Энн Гордон
Райан Мозли
Роберт Стедман
Рэйчел Луиз Мозиз
Глен Мэттью Бойл
Питер Гордон Парсонс
Original Assignee
Кьюбиотикс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013901359A external-priority patent/AU2013901359A0/en
Application filed by Кьюбиотикс Лимитед filed Critical Кьюбиотикс Лимитед
Publication of EA201591996A1 publication Critical patent/EA201591996A1/ru
Publication of EA032501B1 publication Critical patent/EA032501B1/ru
Publication of EA032501B9 publication Critical patent/EA032501B9/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Настоящее изобретение относится к соединениям эпокситиглиана и их применению для содействия заживлению раны. В конкретных вариантах осуществления соединения эпокситиглиана представляют собой соединения эпокситиглиаен-3-она. Описаны способы индукции или содействия заживлению ран, а также способы уменьшения рубцевания и улучшения косметических результатов при заживлении раны. Также описаны соединения и композиции, применяемые для заживления раны.
EA201591996A 2013-04-18 2014-04-17 Способы и композиции для содействия заживлению острой раны и хронической раны EA032501B9 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013901359A AU2013901359A0 (en) 2013-04-18 Methods of Treatment
PCT/AU2014/050018 WO2014169356A1 (en) 2013-04-18 2014-04-17 Methods and compositions for wound healing

Publications (3)

Publication Number Publication Date
EA201591996A1 true EA201591996A1 (ru) 2016-02-29
EA032501B1 EA032501B1 (ru) 2019-06-28
EA032501B9 EA032501B9 (ru) 2019-11-29

Family

ID=51730618

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201591996A EA032501B9 (ru) 2013-04-18 2014-04-17 Способы и композиции для содействия заживлению острой раны и хронической раны

Country Status (30)

Country Link
US (3) US10183921B2 (ru)
EP (1) EP2986615B1 (ru)
JP (1) JP6415538B2 (ru)
KR (1) KR102147796B1 (ru)
CN (1) CN105308052B (ru)
AU (1) AU2014253608B2 (ru)
BR (1) BR112015026388A8 (ru)
CA (1) CA2909653C (ru)
CY (1) CY1121515T1 (ru)
DK (1) DK2986615T3 (ru)
EA (1) EA032501B9 (ru)
ES (1) ES2715105T3 (ru)
HK (1) HK1214256A1 (ru)
HR (1) HRP20190435T1 (ru)
HU (1) HUE043272T2 (ru)
IL (1) IL242137B (ru)
LT (1) LT2986615T (ru)
MX (1) MX365255B (ru)
MY (1) MY184372A (ru)
NZ (1) NZ713954A (ru)
PH (1) PH12015502405B1 (ru)
PL (1) PL2986615T3 (ru)
PT (1) PT2986615T (ru)
RS (1) RS58532B1 (ru)
SG (1) SG11201508588XA (ru)
SI (1) SI2986615T1 (ru)
TR (1) TR201903565T4 (ru)
UA (1) UA118670C2 (ru)
WO (1) WO2014169356A1 (ru)
ZA (1) ZA201508186B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4166145A1 (en) 2016-02-12 2023-04-19 Laimu Corporation Nerve growth promoter and method for producing same, internal preparation, medium additive, cell dilution additive, medium, cell dilution, antioxidant and method for producing same, external preparation, and wound treatment agent and method for producing same
EP3490547A4 (en) * 2016-07-28 2020-04-01 QBiotics Pty Ltd METHOD OF TREATING TUMORS.
HUE063299T2 (hu) 2017-03-23 2024-01-28 QBiotics Pty Ltd Daganatok kezelésére vagy megelõzésére szolgáló kombinációs terápia
KR102249495B1 (ko) 2019-03-15 2021-06-01 주식회사 고위드 피부 관리 장치, 시스템 및 피부 관리 주기 결정 방법
MX2021012449A (es) 2019-04-12 2021-11-12 QBiotics Pty Ltd Metodo para tratar tumores.
AU2020297184A1 (en) * 2019-06-19 2022-01-27 QBiotics Pty Ltd Biofilm disruption
CN112557541B (zh) * 2020-12-08 2022-07-12 河北科技大学 一种枸橼酸马罗匹坦及其有关物质的检测方法
CA3240884A1 (en) * 2021-12-21 2023-06-29 Luca Domenighini Crystalline intermediates
WO2024130329A1 (en) * 2022-12-21 2024-06-27 QBiotics Pty Ltd Crystalline forms, and processes for their production

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641814A (en) * 1991-03-01 1997-06-24 Warner-Lambert Company Antikeratolytic-wound healing compositions and methods for preparing and using same
ATE429925T1 (de) * 2000-07-31 2009-05-15 Univ Bar Ilan Methoden und pharmazeutische zusammensetzungen zur wundheilung
JP2005230051A (ja) 2004-02-17 2005-09-02 Nippon Riko Igaku Kenkyusho:Kk 電位治療器
AU2005279921A1 (en) 2004-08-27 2006-03-09 Advanced Viral Research Corp. Methods for promoting wound healing
US8598229B2 (en) * 2005-12-23 2013-12-03 Qbiotics Limited Tiglien-3-one derivatives
JP4785062B2 (ja) 2007-03-20 2011-10-05 日精樹脂工業株式会社 スクリュ加熱回路を備えた射出装置
AU2010200429A1 (en) * 2009-02-05 2010-08-19 Ecobiotics Ltd Method of reducing or preventing blowfly strike
KR102030694B1 (ko) 2018-02-07 2019-11-18 엘지전자 주식회사 횡자속형 리니어 모터 및 이를 구비한 리니어 압축기

Also Published As

Publication number Publication date
WO2014169356A1 (en) 2014-10-23
MY184372A (en) 2021-04-01
RS58532B1 (sr) 2019-04-30
DK2986615T3 (en) 2019-04-01
TR201903565T4 (tr) 2019-04-22
UA118670C2 (uk) 2019-02-25
US10183921B2 (en) 2019-01-22
CY1121515T1 (el) 2020-05-29
LT2986615T (lt) 2019-03-25
EA032501B9 (ru) 2019-11-29
JP6415538B2 (ja) 2018-10-31
US20190161462A1 (en) 2019-05-30
EP2986615B1 (en) 2018-12-12
EP2986615A1 (en) 2016-02-24
CN105308052A (zh) 2016-02-03
US10822317B2 (en) 2020-11-03
IL242137B (en) 2019-03-31
AU2014253608B2 (en) 2018-06-07
MX365255B (es) 2019-05-28
EA032501B1 (ru) 2019-06-28
PT2986615T (pt) 2019-03-22
AU2014253608A1 (en) 2015-11-26
BR112015026388A2 (pt) 2017-07-25
PH12015502405A1 (en) 2016-02-22
SG11201508588XA (en) 2015-11-27
US20170144981A1 (en) 2017-05-25
EP2986615A4 (en) 2016-03-30
KR102147796B1 (ko) 2020-08-26
PH12015502405B1 (en) 2016-02-22
SI2986615T1 (sl) 2019-05-31
CN105308052B (zh) 2018-07-10
CA2909653A1 (en) 2014-10-23
ES2715105T3 (es) 2019-05-31
ZA201508186B (en) 2019-08-28
NZ713954A (en) 2020-05-29
US20160068499A1 (en) 2016-03-10
HUE043272T2 (hu) 2019-08-28
BR112015026388A8 (pt) 2019-12-31
US10183922B2 (en) 2019-01-22
PL2986615T3 (pl) 2019-06-28
CA2909653C (en) 2022-04-12
JP2016522801A (ja) 2016-08-04
HK1214256A1 (zh) 2016-07-22
HRP20190435T1 (hr) 2019-05-03
MX2015014607A (es) 2016-06-02
KR20160023651A (ko) 2016-03-03

Similar Documents

Publication Publication Date Title
EA201591996A1 (ru) Способы и композиции для заживления раны
EA201492216A1 (ru) Ингибиторы бромодомена и их применение
EA201591591A1 (ru) Соединения карбазола, применяемые в качестве ингибиторов бромодомена
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
EA201690087A1 (ru) Новые квиназолиноны как ингибиторы бромодомена
EA201591327A1 (ru) Замещенные пирролопиримидиновые соединения, их композиции и способы лечения с использованием таких соединений
EA201591524A1 (ru) Производные 2-аминопиримидина для лечения вирусных инфекций
EA201591616A1 (ru) Трифторметил-замещенные аннелированные пиримидины и их применение
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
EA201992133A1 (ru) Производные пиперидино-пиримидина для лечения вирусных инфекций
EA202100040A2 (ru) Применение композиции, содержащей akkermansia muciniphila или её фрагменты, в форме пищевой добавки и для уменьшения тяжести метаболического нарушения
EA201790032A1 (ru) Бициклически замещённые урацилы и их применение
EA202090547A3 (ru) Макроциклические деаза-оксипурины для лечения вирусных инфекций
EA201391507A1 (ru) АНТИТЕЛА ПРОТИВ c-Kit И ИХ ПРИМЕНЕНИЕ
EA201591786A1 (ru) Монотерапия gla для применения в лечении рака
EA201690406A1 (ru) Селективные ингибиторы grp94 и способы их применения
EA201291034A1 (ru) АПТАМЕРЫ К β-NGF И ИХ ПРИМЕНЕНИЕ ПРИ ЛЕЧЕНИИ B-NGF-ОПОСРЕДОВАННЫХ ЗАБОЛЕВАНИЙ И РАССТРОЙСТВ
EA201591427A1 (ru) Соединения и их применения для модуляции гемоглобина
EA201690844A1 (ru) Ингибиторы gsk-3
EA201591618A1 (ru) Замещенные имидазопиридазины
EA201400748A1 (ru) Композиция для обработки семян
EA201591380A1 (ru) АНТАГОНИСТЫ Kv1.3 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
EA201600434A1 (ru) Применение производных бензимидазолпролина
EA201590564A1 (ru) Стабильные составы
EA201690561A1 (ru) Пептидилнитрильные соединения в качестве ингибиторов дипептидилпептидазы i

Legal Events

Date Code Title Description
TH4A Publication of the corrected specification to eurasian patent
TK4A Corrections in published eurasian patents
TH4A Publication of the corrected specification to eurasian patent